gw0742 and Periodontitis

gw0742 has been researched along with Periodontitis* in 1 studies

Other Studies

1 other study(ies) available for gw0742 and Periodontitis

ArticleYear
Emerging role of PPAR-β/δ in inflammatory process associated to experimental periodontitis.
    Mediators of inflammation, 2011, Volume: 2011

    The aim of the present study was to evaluate the contribution of peroxisome proliferator-activated receptor (PPAR-β/δ) in animal model of periodontitis. Male Sprague-Dawley rats were lightly anaesthetized with pentobarbitone (35 mg/kg). Sterile, 2-0 black braided silk thread was placed around the cervix of the lower left first molar and knotted medially. Animals received GW0742 (0.3 mg/kg, 10% DMSO, i.p. after the ligature placement and daily for eight days). At day 8, the gingivomucosal tissue encircling the mandibular first molar was removed. One the eighth day after placement of the ligature, we evaluated (1) NF-κB expression, (2) cytokines expression, (3) iNOS expression, (5) the nitration of tyrosine, (6) apoptosis, and (8) the degree of gingivomucosal tissues injury. Administration of GW0742 significantly decreased all of the parameters of inflammation as described above. Taken together, these results demonstrate that GW0742 exerts an anti-inflammatory role during experimental periodontitis and is able to ameliorate the tissue damage.

    Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Bone Resorption; Capillary Permeability; Cytokines; Dose-Response Relationship, Drug; Male; Neutrophil Infiltration; NF-kappa B; Nitric Oxide Synthase Type II; Periodontitis; PPAR delta; PPAR-beta; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Thiazoles; Tyrosine

2011